UK Companies House feature
DR. REDDY'S LABORATORIES (EU) LIMITED
Cash
£1M
-28.7% vs 2024
Net assets
£35M
+41.2% vs 2024
Employees
182
+7.7% vs 2024
Profit before tax
—
Period ending 2025-03-31
Profile
- Company number
- 02177715
- Status
- Active
- Incorporation
- 1987-10-13
- Last accounts made up
- 2025-03-31
- Account category
- GROUP
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
DR. REDDY'S LABORATORIES (EU) LIMITED
DR. REDDY'S LABORATORIES (EU) LIMITED
DR. REDDY'S LABORATORIES (EU) LIMITED
DR. REDDY'S LABORATORIES (EU) LIMITED
Accounts
7-year trend · latest 2025-03-31
| Metric | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | — | |
| Net profit | — | — | — | — | — | — | £10,270,209 | |
| Cash | — | — | — | £589,168 | — | £1,543,196 | £1,099,633 | |
| Total assets less current liabilities | — | — | — | £27,670,042 | — | £25,783,705 | £37,167,109 | |
| Net assets | — | — | — | £26,910,047 | — | £24,938,377 | £35,208,586 | |
| Equity | £19,104,796 | £25,010,036 | £28,488,352 | £26,910,047 | £24,275,222 | £24,938,377 | £35,208,586 | |
| Average employees | — | — | — | 164 | — | 169 | 182 | |
| Wages | — | — | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Sadofskys
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis in preparing the annual financial statements.”
Subsidiaries
- Dr Reddy's Laboratories (UK) Limited · 100% held · England, CB4 0PE · Manufacture of pharmaceutical products
Significant events
- “The FY25 sales for Dr. Reddy's Laboratories (EU) Limited has increased by 10.8% from revenue £82.14m to £91.02m is mainly in generic business segment. Global generics segment continues to grow year on year in terms of turnover.”
- “Other income for the year ended 31st March 2024 included £9,550,000 which related to settlement of a product related litigation by the company and its affiliates in the United Kingdom.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 32 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MAJJURI, Lakshmi Narayana | Secretary | 2025-10-22 | — | — |
| COBLEY, Christopher James | Director | 2025-04-30 | Jan 1972 | British |
| MANNAM, Venkata Narsimham | Director | 2015-06-29 | May 1968 | Indian |
| O'SHEA, Gerard | Director | 2022-05-17 | Nov 1961 | British |
| YASSAR, Mohammed | Director | 2021-05-06 | Apr 1981 | Indian |
Show 32 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BAHETI, Anup Kumar | Secretary | 2022-05-17 | 2025-10-22 |
| BANDALI, Abbas | Secretary | 2013-07-31 | 2017-08-31 |
| BRODRICK, Andrew, Dr | Secretary | 1997-07-31 | 2002-04-11 |
| CHAKRAPANI, Pakala | Secretary | 2017-08-31 | 2018-08-24 |
| DAVIES, Robin | Secretary | 2002-04-11 | 2004-07-30 |
| DRONAMRAJU, Srinivas | Secretary | 2012-07-29 | 2013-07-31 |
| KUSHWAHA, Sumit, Mr. | Secretary | 2018-08-24 | 2021-11-10 |
| NATU, Sameer | Secretary | 2004-09-27 | 2012-07-29 |
| SANE, Ramanjaneyulu | Secretary | 2021-11-10 | 2022-05-17 |
| TAYLOR, Hilary Margaret | Secretary | — | 1997-07-31 |
| ANANTHANARAYANAN, Raghunathan, Dr | Director | 2012-04-18 | 2014-11-27 |
| BONTHU, Viswanatha | Director | 2002-04-11 | 2013-03-31 |
| BRODRICK, Andrew, Dr | Director | — | 2002-04-11 |
| BRODRICK, Deborah | Director | — | 1994-05-19 |
| CHAPLIN, David Andrew | Director | 2013-04-10 | 2019-01-31 |
| DAVIES, Robin | Director | 1999-05-10 | 2004-07-30 |
| GREGORY, Neil Windsor | Director | 1997-07-31 | 2005-03-14 |
| HARTMAN, Mark | Director | 2002-04-11 | 2008-10-29 |
| KILHAM, Jonathan Paul | Director | 2010-05-03 | 2013-03-31 |
| KOHLI, Subir | Director | 2014-11-27 | 2019-11-29 |
| O'SHEA, Gerard | Director | 2020-01-01 | 2020-08-31 |
| REDDY, Satish | Director | 2005-03-14 | 2018-12-20 |
| REID, Cameron | Director | 2002-04-11 | 2004-04-05 |
| SAWHNEY, Arun | Director | 2004-04-13 | 2008-04-29 |
| SHEPPARD, Alan | Director | 2004-11-01 | 2007-03-31 |
| TROCHE, Clemens Johannes, Mr. | Director | 2018-02-20 | 2019-05-15 |
| TRUSCOTT, Maureen | Director | 1998-01-01 | 2002-04-11 |
| VEMURI, Viswanath | Director | 2010-05-03 | 2013-03-31 |
| VENGANALLORE VENKITESWARAN, Parsuram | Director | 2013-04-10 | 2015-06-29 |
| VISHAR SUBRAMANIAN, Vasudevan | Director | 2002-05-10 | 2010-03-31 |
| WALKER, Andrew | Director | 2020-09-15 | 2022-05-20 |
| WOOD, John Richard | Director | — | 1997-07-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Reddy's Labs Sa | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-05-28 | Active |
Filing timeline
Last 20 of 213 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-23 | AP03 | officers | appoint person secretary company with name date |
| 2025-10-23 | TM02 | officers | termination secretary company with name termination date |
| 2025-06-25 | MR04 | mortgage | mortgage satisfy charge full |
| 2025-06-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-06 | AA | accounts | accounts with accounts type group |
| 2025-05-06 | AP01 | officers | appoint person director company with name date |
| 2025-04-28 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-04-28 | PSC09 | persons-with-significant-control | withdrawal of a person with significant control statement |
| 2024-06-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-05-03 | AA | accounts | accounts with accounts type group |
| 2023-06-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-05-30 | AA | accounts | accounts with accounts type group |
| 2022-09-14 | AA | accounts | accounts with accounts type group |
| 2022-06-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-05-26 | TM01 | officers | termination director company with name termination date |
| 2022-05-19 | AP03 | officers | appoint person secretary company with name date |
| 2022-05-19 | AP01 | officers | appoint person director company with name date |
| 2022-05-19 | TM02 | officers | termination secretary company with name termination date |
| 2021-12-23 | AA | accounts | accounts with accounts type group |
| 2021-11-20 | TM02 | officers | termination secretary company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires EBIT (operating profit / PBT) — not present in the latest extracted accounts.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.